Answers are grounded in this paper and cite their sources.
Chemoresistance is a major problem in the treatment of ovarian cancer patients and leads to poor prognosis, but its underlying mechanism remains elusive. Accumulating evidences have found that the aberrant regulation of the protein ubiquitination pathway plays an essential role in ovarian cancer chemoresistance. 1 , 2 , 3 However, it is unclear whether and how deubiquitinase-USP11 involves in ovarian cancer chemoresistance.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: